524414 Stock Overview
Primarily engages in the manufacture of pharmaceutical formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Norris Medicines Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹21.53 |
| 52 Week High | ₹27.74 |
| 52 Week Low | ₹10.70 |
| Beta | 0.12 |
| 11 Month Change | 19.61% |
| 3 Month Change | 63.60% |
| 1 Year Change | 66.64% |
| 33 Year Change | 127.35% |
| 5 Year Change | 498.06% |
| Change since IPO | 84.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524414 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -14.2% | -0.2% | 0.3% |
| 1Y | 66.6% | 40.5% | 27.3% |
Return vs Industry: 524414 exceeded the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 524414 exceeded the Indian Market which returned 27.3% over the past year.
Price Volatility
| 524414 volatility | |
|---|---|
| 524414 Average Weekly Movement | 8.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524414's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524414's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 45 | Vimal Shah | www.norrispharma.com |
Norris Medicines Limited primarily engages in the manufacture of pharmaceutical formulations in India. It offers products in the fields of antibiotic, anti-inflammatory-pain management, analgesic, gastrointestinal, dermatological, nutrition, anti-malarial, anti-emetic, cough/cold, dental, diabetic, and cardiac, as well as other fields in various formulations, including tablets, capsules, liquid orals, and copical ointments. The company also offers contract and loan license manufacturing services.
Norris Medicines Limited Fundamentals Summary
| 524414 fundamental statistics | |
|---|---|
| Market cap | ₹226.62m |
| Earnings (TTM) | -₹8.23m |
| Revenue (TTM) | ₹41.40m |
5.2x
P/S Ratio-26.2x
P/E RatioIs 524414 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524414 income statement (TTM) | |
|---|---|
| Revenue | ₹41.40m |
| Cost of Revenue | ₹14.17m |
| Gross Profit | ₹27.23m |
| Other Expenses | ₹35.46m |
| Earnings | -₹8.23m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.82 |
| Gross Margin | 65.78% |
| Net Profit Margin | -19.88% |
| Debt/Equity Ratio | -150.3% |
How did 524414 perform over the long term?
See historical performance and comparison